Vivid Vision, Inc.

Vivid Vision, Inc. develops innovative vision training systems utilizing virtual reality technology to treat conditions like amblyopia and strabismus, enhancing visual capabilities for patients of all ages. Vivid Vision is focused on transforming vision therapy with advanced technology. Founded in 2013 in San Francisco, US, by James Blaha, Manish Gupta, and Tuan Tran, the company has completed five funding deals, with a notable investment of USD 2.

2 mn in a Seed round on March 13, 2020, from investors including Anorak Ventures and Humana Ventures. James Blaha, serving as CEO, has a background that includes founding other ventures. Vivid Vision specializes in advanced vision training systems, primarily targeting conditions such as amblyopia (lazy eye), strabismus (crossed eyes), and convergence insufficiency. Their core products include Vivid Vision Clinical, used in eye care practices under professional supervision, and Vivid Vision Home, designed for independent patient training.

Utilizing cutting-edge virtual reality hardware, these products enhance binocular vision through interactive exercises. The company caters to a diverse client base, including eye care professionals, clinics, and patients, with products available in various international markets, excluding the United States at this time. Vivid Vision's revenue model is based on partnerships with eye care providers who utilize the company's training systems as part of their offerings. Clinics typically pay for licenses to access Vivid Vision's products, which allows them to provide vision therapy to their patients.

The company also offers subscription-based services for software updates and new training modules, ensuring accessibility for users from children to adults, with pricing tailored to the needs of partnering clinics and their patient demographics. Vivid Vision plans to launch new products designed to enhance their vision training offerings, though specific release dates have not been disclosed. The company aims to expand into new markets, specifically targeting regions in Europe and Asia by the end of 2023. The recent funding of USD 2.

2 mn will support these initiatives, particularly in product development and market entry strategies.